180 related articles for article (PubMed ID: 34330893)
1. DEPDC1B regulates the progression of human chordoma through UBE2T-mediated ubiquitination of BIRC5.
Wang L; Tang L; Xu R; Ma J; Tian K; Liu Y; Lu Y; Wu Z; Zhu X
Cell Death Dis; 2021 Jul; 12(8):753. PubMed ID: 34330893
[TBL] [Abstract][Full Text] [Related]
2. DEPDC1B knockdown inhibits the development of malignant melanoma through suppressing cell proliferation and inducing cell apoptosis.
Xu Y; Sun W; Zheng B; Liu X; Luo Z; Kong Y; Xu M; Chen Y
Exp Cell Res; 2019 Jun; 379(1):48-54. PubMed ID: 30880030
[TBL] [Abstract][Full Text] [Related]
3. DEPDC1B promotes colorectal cancer via facilitating cell proliferation and migration while inhibiting apoptosis.
Han F; Cheng C; Xu Q; Chen J; Yang Z; Liu J
Cell Cycle; 2023 Jan; 22(1):131-143. PubMed ID: 36016512
[TBL] [Abstract][Full Text] [Related]
4. DEP domain containing 1B (DEPDC1B) exerts the tumor promoter in hepatocellular carcinoma through activating p53 signaling pathway via kinesin family member 23 (KIF23).
Shen E; Zhang J; Lu Y
Bioengineered; 2022 Jan; 13(1):1103-1114. PubMed ID: 34983303
[TBL] [Abstract][Full Text] [Related]
5. Overexpressed DEPDC1B contributes to the progression of hepatocellular carcinoma by CDK1.
Dang XW; Pan Q; Lin ZH; Wang HH; Li LH; Li L; Shen DQ; Wang PJ
Aging (Albany NY); 2021 May; 13(16):20094-20115. PubMed ID: 34032605
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
[TBL] [Abstract][Full Text] [Related]
7. DEPDC1B is involved in the proliferation, metastasis, cell cycle arrest and apoptosis of colon cancer cells by regulating NUP37.
Xiong H; Li Y; Liu M
Mol Med Rep; 2023 Jun; 27(6):. PubMed ID: 37203403
[TBL] [Abstract][Full Text] [Related]
8. DEPDC1B is a tumor promotor in development of bladder cancer through targeting SHC1.
Lai CH; Xu K; Zhou J; Wang M; Zhang W; Liu X; Xiong J; Wang T; Wang Q; Wang H; Xu T; Hu H
Cell Death Dis; 2020 Nov; 11(11):986. PubMed ID: 33203836
[TBL] [Abstract][Full Text] [Related]
9. UBE2T mediates SORBS3 ubiquitination to enhance IL-6/STAT3 signaling and promote lung adenocarcinoma progression.
Pu J; Wang B; Zhang D; Wang K; Yang Z; Zhu P; Song Q
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23743. PubMed ID: 38816989
[TBL] [Abstract][Full Text] [Related]
10. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
Hao P; Kang B; Li Y; Hao W; Ma F
Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
[TBL] [Abstract][Full Text] [Related]
11. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT.
Huang P; Guo Y; Zhao Z; Ning W; Wang H; Gu C; Zhang M; Qu Y; Zhang H; Song Y
Aging (Albany NY); 2020 Jun; 12(11):10275-10289. PubMed ID: 32491994
[TBL] [Abstract][Full Text] [Related]
12. miR-543 impairs breast cancer cell phenotypes by targeting and suppressing ubiquitin-conjugating enzyme E2T (UBE2T).
Li L; Li Q
Bioengineered; 2021 Dec; 12(2):12394-12406. PubMed ID: 34787051
[TBL] [Abstract][Full Text] [Related]
13. UBE2T promotes glioblastoma malignancy through ubiquitination-mediated degradation of RPL6.
Tao X; Wu X; Zhou P; Yu X; Zhao C; Peng X; Zhang K; Shen L; Peng J; Yang L
Cancer Sci; 2023 Feb; 114(2):521-532. PubMed ID: 36156329
[TBL] [Abstract][Full Text] [Related]
14. Correction to: DEPDC1B regulates the progression of human chordoma through UBE2T-mediated ubiquitination of BIRC5.
Wang L; Tang L; Xu R; Ma J; Tian K; Liu Y; Lu Y; Wu Z; Zhu X
Cell Death Dis; 2022 Jul; 13(7):631. PubMed ID: 35864096
[No Abstract] [Full Text] [Related]
15. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
Guo J; Wang M; Wang JP; Wu CX
World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
[TBL] [Abstract][Full Text] [Related]
16. UBE2T knockdown inhibits gastric cancer progression.
Luo C; Yao Y; Yu Z; Zhou H; Guo L; Zhang J; Cao H; Zhang G; Li Y; Jiao Z
Oncotarget; 2017 May; 8(20):32639-32654. PubMed ID: 28427240
[TBL] [Abstract][Full Text] [Related]
17. MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T.
Wu Y; Zhang C; Peng D; He S; Huang C; Qian J; Zhu W; Feng N; Gong Y; Li X; Zhou L
Hum Cell; 2022 Mar; 35(2):542-556. PubMed ID: 35129808
[TBL] [Abstract][Full Text] [Related]
18. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
19. ZNF146 regulates cell cycle progression via TFDP1 and DEPDC1B in ovarian cancer cells.
Zhao R; Song N; Ning X; Chen X; Ma R
Reproduction; 2024 Jul; 168(1):. PubMed ID: 38614125
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA LINC00525 interacts with miR-31-5p and miR-125a-5p to act as an oncogenic molecule in spinal chordoma.
Gong F; Wang X; Sun Q; Su X; Hu X; Liu B
Biochem Biophys Res Commun; 2021 Jan; 536():80-87. PubMed ID: 33370717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
